Market dynamics Tariff impact / tariffs Adjusted earnings per share Acquisition (Vascular Intervention acquisition) NewCo Constant currency growth Operating margin FreeSolve technology Core business Strategic update / strategy Strategic rationale Simplified manufacturing footprint Spin Better than expected Cash flow from operations Value creation Shareholder value / maximizing shareholder value Operational excellence / operational execution Patient outcomes / patient care Constant currency basis Foreign exchange impact Year- over-year growth Revenue / revenue growth / revenues Interventional business Potential sale of Newco Barrigel Expressions of interest Integration activities / integration Investor event Focused strategic direction Unlock value Titan SGS stapler Sequential improvement Guidance / updated financial guidance Long- term growth Cost inflation Capital allocation strategy Future outlook Parallel paths Gross margin Guiding principles Volume- based procurement In line with expectations UroLift Clinical data Market dynamics Tariff impact / tariffs Adjusted earnings per share Acquisition (Vascular Intervention acquisition) NewCo Constant currency growth Operating margin FreeSolve technology Core business Strategic update / strategy Strategic rationale Simplified manufacturing footprint Spin Better than expected Cash flow from operations Value creation Shareholder value / maximizing shareholder value Operational excellence / operational execution Patient outcomes / patient care Constant currency basis Foreign exchange impact Year- over-year growth Revenue / revenue growth / revenues Interventional business Potential sale of Newco Barrigel Expressions of interest Integration activities / integration Investor event Focused strategic direction Unlock value Titan SGS stapler Sequential improvement Guidance / updated financial guidance Long- term growth Cost inflation Capital allocation strategy Future outlook Parallel paths Gross margin Guiding principles Volume- based procurement In line with expectations UroLift Clinical data
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Market dynamics
Tariff impact / tariffs
Adjusted earnings per share
Acquisition (Vascular Intervention acquisition)
NewCo
Constant currency growth
Operating margin
FreeSolve technology
Core business
Strategic update / strategy
Strategic rationale
Simplified manufacturing footprint
Spin
Better than expected
Cash flow from operations
Value creation
Shareholder value / maximizing shareholder value
Operational excellence / operational execution
Patient outcomes / patient care
Constant currency basis
Foreign exchange impact
Year-over-year growth
Revenue / revenue growth / revenues
Interventional business
Potential sale of Newco
Barrigel
Expressions of interest
Integration activities / integration
Investor event
Focused strategic direction
Unlock value
Titan SGS stapler
Sequential improvement
Guidance / updated financial guidance
Long-term growth
Cost inflation
Capital allocation strategy
Future outlook
Parallel paths
Gross margin
Guiding principles
Volume-based procurement
In line with expectations
UroLift
Clinical data